🎉 M&A multiples are live!
Check it out!

Audientes Valuation Multiples

Discover revenue and EBITDA valuation multiples for Audientes and similar public comparables like Sopharma, Etropal, and Farmaceutica Remedia.

Audientes Overview

About Audientes

Audientes AS is a Danish hearing technology company specializing in smart, self-fitting, and affordable hearing aids. Audientes’ hearing aid solutions portfolio comprises Ven, a self-fitting, binaural hearing aid designed for individuals with severe to profound hearing loss in one or both ears, and Companion, a hearable that doubles as a premium Bluetooth headset, designed for individuals seeking enhanced hearing in specific situations. It offers crystal-clear sound, natural speech clarity, and Bluetooth connectivity for calls and media streaming.


Founded

2014

HQ

Sweden
Employees

8

Website

audientes.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$1.7M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Audientes Financials

Audientes has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Audientes achieved revenue of $0.3M and an EBITDA of -$0.8M.

Audientes expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Audientes valuation multiples based on analyst estimates

Audientes P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $0.4M $0.3M XXX XXX XXX
Gross Profit -$0.7M -$0.3M XXX XXX XXX
Gross Margin -164% -111% XXX XXX XXX
EBITDA -$1.2M -$0.8M XXX XXX XXX
EBITDA Margin -306% -326% XXX XXX XXX
Net Profit -$3.7M -$2.0M XXX XXX XXX
Net Margin -916% -789% XXX XXX XXX
Net Debt n/a $0.6M XXX XXX XXX

Financial data powered by Morningstar, Inc.

Audientes Stock Performance

As of May 13, 2025, Audientes's stock price is DKK 0 (or $0).

Audientes has current market cap of DKK 8.2M (or $1.2M), and EV of DKK 11.2M (or $1.7M).

See Audientes trading valuation data

Audientes Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.7M $1.2M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Audientes Valuation Multiples

As of May 13, 2025, Audientes has market cap of $1.2M and EV of $1.7M.

Audientes's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Audientes's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Audientes and 10K+ public comps

Audientes Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.7M XXX XXX XXX
EV/Revenue 6.6x XXX XXX XXX
EV/EBITDA -2.0x XXX XXX XXX
P/E -0.8x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF -1.7x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Audientes Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Audientes Valuation Multiples

Audientes's NTM/LTM revenue growth is n/a

Audientes's revenue per employee for the last fiscal year averaged $32K, while opex per employee averaged n/a for the same period.

Over next 12 months, Audientes's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Audientes's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Audientes and other 10K+ public comps

Audientes Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -36% XXX XXX XXX XXX
EBITDA Margin N/A XXX XXX XXX XXX
EBITDA Growth -32% XXX XXX XXX XXX
Rule of 40 (SaaS-only) N/A XXX XXX XXX XXX
Revenue per Employee $32K XXX XXX XXX XXX
Opex per Employee n/a XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue n/a XXX XXX XXX XXX
Opex to Revenue 5% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Audientes Public Comps

See public comps and valuation multiples for Medical Supplies comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Ansell XXX XXX XXX XXX XXX XXX
Polymed XXX XXX XXX XXX XXX XXX
Farmaceutica Remedia XXX XXX XXX XXX XXX XXX
Etropal XXX XXX XXX XXX XXX XXX
Sopharma XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Audientes M&A and Investment Activity

Audientes acquired  XXX companies to date.

Last acquisition by Audientes was  XXXXXXXX, XXXXX XXXXX XXXXXX . Audientes acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Audientes

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Audientes

When was Audientes founded? Audientes was founded in 2014.
Where is Audientes headquartered? Audientes is headquartered in Sweden.
How many employees does Audientes have? As of today, Audientes has 8 employees.
Is Audientes publicy listed? Yes, Audientes is a public company listed on SAT.
What is the stock symbol of Audientes? Audientes trades under AUDNTS ticker.
When did Audientes go public? Audientes went public in 2022.
Who are competitors of Audientes? Similar companies to Audientes include e.g. Ansell, Polymed, Farmaceutica Remedia, Etropal.
What is the current market cap of Audientes? Audientes's current market cap is $1.2M
What is the current revenue growth of Audientes? Audientes revenue growth between 2023 and 2024 was -36%.
Is Audientes profitable? Yes, Audientes is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.